GLP-1s: Promise, Pitfalls, and What Comes Next @MITClubofNorthernCalifornia
GLP-1s: Promise, Pitfalls, and What Comes Next  @MITClubofNorthernCalifornia
Uploaded November 2025 | Updated November 2026, 19 hours ago
On October 29th, 2025, the MIT Club of Northern California brings together clinicians and digital health innovators to explore the real-world lessons emerging from the GLP-1 revolution.

GLP-1 medications like Ozempic and Zepbound have changed the conversation around obesity and metabolic disease, yet they’ve also introduced new challenges:

- How can patients sustain results once they stop medication?

- Why are behavioral and nutritional interventions still essential?

- What are the pitfalls around side effects, supply constraints, and cost?

- And what role should employers and payers play in ensuring access and value?

Join us for an engaging evening of dinner, discussion, and debate as we unpack the clinical, behavioral, and economic realities of GLP-1s, and look ahead to what’s next in obesity and metabolic care.

Whether you’re a patient, healthcare professional, policymaker, or employer, you’ll walk away with a clearer understanding of where the science is headed, how nutrition-first and behavioral approaches fit in, and how we can make the future of obesity care both effective and sustainable.
GLP-1s: Promise, Pitfalls, and What Comes NextMeet Isabelle Liu from MITCNCAI for Autonomous ScienceThe Youth Mental Health Crisis – Understanding Anxiety and Depression in TeensFinancing Deep Tech with Prof. Andrew Lo, Dir. of MIT Lab for Financial Engineering | Fin-TrackMental Health: Will Digital Win?Beyond Distraction: Practical Strategies for Living with ADHD2nd Annual Homebuying Panel Discussion: What A Difference A Year MakesValue Based Care: Are We There Yet?Meet Dr. Neerja Aggarwal, the New President of MITCNC11:30am:  Practical Deep Learning: How It Is Used in Production and Already Revolutionizing EnterpriNATO and the War in Ukraine
MIT Club of Northern California |

GLP-1s: Promise, Pitfalls, and What Comes Next

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER